Public Meeting on the Reauthorization of BsUFA Dec 3 from 9am to 12pm EST

https://www.eventbrite.com/e/public-meeting-on-the-reauthorization-of-bsufa-tickets-1527420849879?aff=oddtdtcreator&utm_medium=email&utm_source=govdelivery FDA Announces Public Meeting on BsUFA Reauthorization December 3, 2025 from 9 AM – 12 PM EST Hybrid (In-person/Virtual) The U.S. Food and Drug Administration is hosting a public meeting on the fourth reauthorization of the Biosimilar User Fee Act (BsUFA) on December 3, 2025. The meeting will provide stakeholders an opportunity to share input on: Program performance and potential improvements User fee structures and performance commitments Stakeholder needs for biosimilar product development and review Your participation and input are valuable as FDA prepares for the next reauthorization cycle. For more information about BsUFA and the reauthorization process, visit: Public Meeting on the Reauthorization of the Biosimilar User Fee Act (BsUFA) https://www.fda.gov/industry/public-meeting-reauthorization-biosimilar-user-fee-act-bsufa-12032025?utm_medium=email&utm_source=govdelivery